Report Company Directory

INOLIFE TECHNOLOGIES INC

Inotek Pharmaceuticals Corp

• Inotek Pharmaceuticals Announces Filing of Preliminary Proxy Statement for Proposed Merger with Clinical-stage Gene Therapy Company, Rocket Pharmaceuticals by BusinessWire
• INSERTING and REPLACING Inotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals to Advance Pipeline of First-in-Class Gene Therapies for Rare Diseases by BusinessWire
• Inotek Pharmaceuticals Corporation Reports Second Quarter 2017 Financial Results and Operational Highlights by BusinessWire
• Inotek Pharmaceuticals Announces Top-line Results of Phase 2 Fixed-dose Combination Trial of Trabodenoson and Provides Corporate Update by BusinessWire
• Inotek Pharmaceuticals Corporation Reports First Quarter 2017 Financial Results and Operational Highlights by BusinessWire
• Inotek Pharmaceuticals Presents Preclinical Data on Trabodenoson at the Association for Research in Vision and Ophthalmology (ARVO) 2017 Annual Meeting by BusinessWire
• Inotek Completes Patient Recruitment in Phase 2 Trial of a Fixed-dose Combination (FDC) of Trabodenoson and Latanoprost by BusinessWire
• Inotek Pharmaceuticals Corporation Reports Fiscal Year 2016 Financial Results and Operational Highlights by BusinessWire
• Inotek Pharmaceuticals Announces Participation at Upcoming Investor Conferences by BusinessWire
• Inotek Pharmaceuticals Announces Poster Presentations on Trabodenoson at the American Glaucoma Society 2017 Annual Meeting by BusinessWire

Inotera Memories Inc

• Ford Equity International Rating and Forecast Report by Ford Equity Research

INOTIV INC

• Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025 by GlobeNewsWire
• Inotiv Reports First Quarter Financial Results for Fiscal 2025 and Provides Business Update by GlobeNewsWire
• Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025 by GlobeNewsWire
• Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million by GlobeNewsWire
• Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million by GlobeNewsWire
• Inotiv, Inc. Announces Pricing of Public Offering of 6,000,000 Common Shares by GlobeNewsWire
• Inotiv, Inc. Launches Proposed Public Offering of Common Shares by GlobeNewsWire
• Vital Signs: Actionable charts by Vermilion Research
• Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™ by GlobeNewsWire
• Inotiv, Inc. to Report Fiscal 2024 Fourth Quarter and Full Year Results and Host Conference Call on Tuesday, December 3, 2024 by GlobeNewsWire

Inoue Rubber Thailand

• A director bought 31,500 shares at 23.219THB and by SmartInsider
• Ford Equity International Rating and Forecast Report by Ford Equity Research